Factors Associated With Intraocular Inflammation in Neovascular Age-Related Macular Degeneration Patients Treated With Brolucizumab
Investigative Opthalmology & Visual Science · 2024
DOI: 10.1167/iovs.65.1.8 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Investigative Opthalmology & Visual Science, 2024. Verfasst von Yuto Hashimoto und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Jichi Medical University, Tochigi, Japan. Hauptthemen laut MEDLINE: Macular Degeneration, Uveitis, Wet Macular Degeneration. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
To identify factors associated with intraocular inflammation (IOI) in patients with neovascular age-related macular degeneration (nAMD) treated with brolucizumab.
Methods
In this prospective observational study, we collected aqueous humor samples from 96 eyes of 96 patients receiving treatment with brolucizumab; IOI subsequently developed in 19 eyes of 19 patients. To identify cytokines upregulated in eyes with subsequent development of IOI, we compared the aqueous humor cytokine levels between the IOI and non-IOI groups. We also collected plasma from 20 patients who developed IOI and 20 age- and sex-matched controls to identify differences in plasma biomarkers and the subfraction of CD4+ cells. Using stepwise variable selection and multivariate binary regression analysis, we developed an algorithm that accurately assessed the likelihood of IOI occurrence.
Results
The IOI group showed elevated aqueous humor levels of P-selectin (584 vs. 324 pg/mL, P = 0.013), TNF-α (0.89 vs. 0.60 pg/mL, P = 0.018), and IL-1α (2.0 vs. 1.4 pg/mL, P = 0.035) compared with the non-IOI group. Serum MMP-9 concentrations were higher in the IOI group than the non-IOI group (18,310 vs. 13,450 pg/mL, P = 0.029). Furthermore, the percentage of Th2 cells was significantly decreased in the IOI compared with the non-IOI group (3.1% vs. 4.2%, P = 0.013). The receiver operating characteristic curves for the optimal models showed an area under the curve ranging from 0.71 to 0.89, indicating good performance.
Conclusions
The combination of elevated concentrations of multiple aqueous humor cytokines and of serum MMP-9 and a lower number of plasma Th2 cells is associated with brolucizumab-related IOI in patients with nAMD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Ophthalmology, Jichi Medical University, Tochigi, Japan.
- Department of Ophthalmology, Japan Community Healthcare Organization Tokyo Shinjuku Medical Center, Tokyo, Japan.
- Department of Ophthalmology and Micro-Technology, Yokohama City University Medical Center, Yokohama, Japan.
- The Ophthalmology & Visual Sciences Academic Clinical Program, Duke-NUS Medical School, National University of Singapore, Singapore.
Zitieren
APA
Hashimoto, Y., Inoda, S., Takahashi, H., Takahashi, R., Yoshida, H., Fujino, Y., Sakamoto, S., Kawashima, H., & Yanagi, Y. (2024). Factors Associated With Intraocular Inflammation in Neovascular Age-Related Macular Degeneration Patients Treated With Brolucizumab. Investigative Opthalmology & Visual Science. https://doi.org/10.1167/iovs.65.1.8
Vancouver
Hashimoto Y, Inoda S, Takahashi H, Takahashi R, Yoshida H, Fujino Y, et al. Factors Associated With Intraocular Inflammation in Neovascular Age-Related Macular Degeneration Patients Treated With Brolucizumab. Investigative Opthalmology & Visual Science. 2024. doi:10.1167/iovs.65.1.8
BibTeX
@article{Hashimoto2024,
author = {Hashimoto, Yuto and Inoda, Satoru and Takahashi, Hidenori and Takahashi, Ryota and Yoshida, Hana and Fujino, Yujiro and Sakamoto, Shinichi and Kawashima, Hidetoshi and Yanagi, Yasuo},
title = {Factors Associated With Intraocular Inflammation in Neovascular Age-Related Macular Degeneration Patients Treated With Brolucizumab},
journal = {Investigative Opthalmology & Visual Science},
year = {2024},
doi = {10.1167/iovs.65.1.8}
}
EUVIMED